SCHEMBL28899645

SCHEMBL28899645

CCCCCCCCC1CC(F)(F)CCC1(C(N)=O)C(CC)c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.34
ASAH1 Q13510 1/20 0.34
ACER2 Q5QJU3 1/20 0.34
NAAA Q02083 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
CYP2C19 P33261 1/20 0.33
OPRM1 P35372 1/20 0.33
OPRD1 P41143 1/20 0.33
OPRK1 P41145 1/20 0.33
OPRL1 P41146 1/20 0.33
CYSLTR2 Q9NS75 1/20 0.33
CYSLTR1 Q9Y271 1/20 0.33
KCNQ3 O43525 1/20 0.33
KCNQ2 O43526 1/20 0.33
KCNQ4 P56696 1/20 0.33
KCNQ5 Q9NR82 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28899708 0.86 NR5A2 (0.38) ASAH1NAAAOPRM1OPRD1OPRK1
SCHEMBL28899643 0.72 OPRK1 (0.40) ALDH1A1ASAH1ACER2NAAAOPRM1
SCHEMBL28899706 0.66 OPRM1 (0.43) ALDH1A1ASAH1ACER2NAAAOPRM1
SCHEMBL30632554 0.64 ALDH1A1 (0.40) ALDH1A1TSHROPRK1
SCHEMBL18342994 0.64 ALDH1A1 (0.40) ALDH1A1TSHR
SCHEMBL5815457 0.63 CHRM2 (0.40) ALDH1A1TSHR
SCHEMBL5818428 0.60 MME (0.40) OPRM1OPRD1OPRK1OPRL1KCNQ2
SCHEMBL28046467 0.60 ALOX5 (0.40) ALDH1A1CYP1A2CYP3A4TSHR
SCHEMBL15390385 0.59 SLC6A2 (0.39) CYP2C19KCNQ2
Decane SCHEMBL28986149 0.58 MTOR (0.51) ALDH1A1ASAH1ACER2NAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115414480-A Dianhydrogalactitol in combination with radiation for treatment of non-small cell lung cancer and glioblastoma multiforme 德玛医药 2022-12-02 CN disclosed